Hsiao, Elaine,Wu, Wei-Li,Mazmanian, Sarkis K.,Patterson, Paul H.
申请号：
AU2015339281
公开号：
AU2015339281A1
申请日:
2015.10.28
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
Some embodiments include probiotics for use in treatment of one or more autism spectrum disorder (ASD) or epilepsy in a subject in need thereof. The probiotics can comprise Bacteroides bacteria (e.g., B. fragilis). In some embodiments, the subject is identified in need of treatment ASD or epilepsy based a combination of behavioral symptoms and optional genetic markers. Upon treatment, one or more ASD-related behaviors are improved in the subject.
